Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Diseases, Papulosquamous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02188641
What this trial is testing

Effect of Exercise and Diet on Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
University of Alexandria 55
Not applicableStudy completedNCT04402554
What this trial is testing

Survey of Cannabis Use in Patients With Chronic Inflammatory Arthritis

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisPsoriatic Arthritis
University Hospital, Clermont-Ferrand 501
Not applicableUnknownNCT06213688
What this trial is testing

Involvement of Pollutants in Atopic Dermatitis and Psoriasis

Who this might be right for
PsoriasisAtopic Dermatitis
Assistance Publique Hopitaux De Marseille 64
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07150988
What this trial is testing

A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Haisco Pharmaceutical Group Co., Ltd. 150
Post-approval studies (Phase 4)Looking for participantsNCT04347473
What this trial is testing

ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.

Who this might be right for
Psoriasis
Psoriasis Treatment Center of Central New Jersey 25
Large-scale testing (Phase 3)Study completedNCT02024646
What this trial is testing

Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Bausch Health Americas, Inc. 484
Testing effectiveness (Phase 2)Study completedNCT01225731
What this trial is testing

Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 355
Large-scale testing (Phase 3)Study completedNCT03535194
What this trial is testing

Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,484
Post-approval studies (Phase 4)Study completedNCT04645355
What this trial is testing

Guselkumab Immunogenetics

Who this might be right for
Psoriasis GuttatePlaque Psoriasis
University of California, San Francisco 17
Not applicableStudy completedNCT00005660
What this trial is testing

The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases

Who this might be right for
Basal Cell CarcinomaKeratosis Palmaris et PlantarisPsoriasis
National Cancer Institute (NCI) 130
Not applicableStudy completedNCT00422617
What this trial is testing

Evaluate the Efficacy and Safety of One Course of Amevive in Taiwan Patients

Who this might be right for
Chronic Plaque Psoriasis
Uni-Pharma 40
Testing effectiveness (Phase 2)Looking for participantsNCT07486960
What this trial is testing

Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

Who this might be right for
Psoriatic Arthritis
Merck Sharp & Dohme LLC 140
Not applicableStudy completedNCT05942794
What this trial is testing

Identification of Oral Lesions Through an Autofluorescence System

Who this might be right for
Oral LeukoplakiaAutofluorescenceSecondary Prevention+4 more
Federico II University 200
Not applicableActive Not RecruitingNCT03661866
What this trial is testing

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Who this might be right for
Atopic DermatitisAlopecia AreataHidradenitis Suppurativa+3 more
Target PharmaSolutions, Inc. 15,000
Testing effectiveness (Phase 2)Ended earlyNCT01018810
What this trial is testing

Adults With Plaque Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 8
Large-scale testing (Phase 3)Study completedNCT02581345
What this trial is testing

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque PsoriasisPsoriasis
Momenta Pharmaceuticals, Inc. 572
Very early researchEnrolling By InvitationNCT07050810
What this trial is testing

Thera-Clean® Microbubbles System in Patients With Skin Diseases

Who this might be right for
Epidermolysis BullosaIchthyosisAtopic Dermatitis+1 more
Northwestern University 20
Not applicableStudy completedNCT03099083
What this trial is testing

Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab

Who this might be right for
Psoriasis
AbbVie 97
Large-scale testing (Phase 3)Study completedNCT01139580
What this trial is testing

The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis

Who this might be right for
Psoriasis
Stiefel, a GSK Company 363
Not applicableStudy completedNCT05223062
What this trial is testing

Medication Adherence in Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Bezmialem Vakif University 50
Next Page